Markel Group (NYSE:MKL) Price Target Lowered to $1,950.00 at Truist Financial

Markel Group (NYSE:MKL) had its price target reduced by Truist Financial from $2,100.00 to $1,950.00 in a research report report published on Thursday morning, Marketbeat.com reports. They currently have a hold rating on the insurance provider’s stock.

A number of other equities research analysts have also recently issued reports on the company. Weiss Ratings restated a “buy (b+)” rating on shares of Markel Group in a research note on Friday, March 27th. Wall Street Zen upgraded Markel Group from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Brean Capital assumed coverage on Markel Group in a research note on Tuesday, March 24th. They issued a “neutral” rating and a $2,100.00 price objective on the stock. Finally, Zacks Research cut Markel Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, January 19th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $2,025.00.

Markel Group Trading Up 0.9%

NYSE MKL opened at $1,774.85 on Thursday. The stock has a market capitalization of $22.27 billion, a price-to-earnings ratio of 12.79 and a beta of 0.79. Markel Group has a one year low of $1,719.41 and a one year high of $2,207.59. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.63 and a quick ratio of 0.63. The business’s fifty day moving average is $1,948.66 and its 200-day moving average is $2,018.57.

Markel Group (NYSE:MKL) last released its earnings results on Tuesday, April 28th. The insurance provider reported ($18.90) EPS for the quarter, missing analysts’ consensus estimates of $26.38 by ($45.28). The business had revenue of $2.82 billion for the quarter, compared to the consensus estimate of $3.66 billion. Markel Group had a return on equity of 7.90% and a net margin of 10.85%. Equities research analysts predict that Markel Group will post 117.5 EPS for the current year.

Insider Transactions at Markel Group

In related news, CEO Simon Wilson sold 100 shares of the business’s stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $2,079.48, for a total value of $207,948.00. Following the sale, the chief executive officer directly owned 2,397 shares in the company, valued at approximately $4,984,513.56. The trade was a 4.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.08% of the company’s stock.

Institutional Investors Weigh In On Markel Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Valley National Advisers Inc. bought a new stake in shares of Markel Group during the fourth quarter valued at about $25,000. Fideuram Asset Management Ireland dac bought a new stake in shares of Markel Group during the fourth quarter valued at about $26,000. Reflection Asset Management bought a new stake in shares of Markel Group during the fourth quarter valued at about $26,000. Measured Wealth Private Client Group LLC bought a new stake in shares of Markel Group during the third quarter valued at about $29,000. Finally, V Square Quantitative Management LLC bought a new stake in shares of Markel Group during the fourth quarter valued at about $32,000. 77.12% of the stock is currently owned by institutional investors.

About Markel Group

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.